PURPOSE: The Institute of Medicine (IOM) recommends cancer survivors receive survivorship care plans after completing active cancer treatment. However, care plan creation requires significant time and effort, contributing to diminished adoption of this recommendation. Electronic health record (EHR) systems have been proposed as a solution. We assessed the feasibility of creating and delivering care plans within an EHR system. METHODS: Thirty-eight breast cancer survivors without existing care plans were recruited during a follow-up visit to their primary oncologist. Using an EHR template, an oncologist created an individualized care plan for each participant. Time spent creating each plan was recorded. Participant use and feedback were collected. RESULTS: Participants enrolled a median of 19.7 months after diagnosis (range, 4.3 to 57 months). A minority of IOM-recommended plan elements could be automatically imported without any manual entry. The majority of elements required interpretation and manual import by the clinician. However, with an established infrastructure for importing elements, the time needed to create a care plan electronically was short (median, 3 minutes; range 2 to 12 minutes). Most survivors (n = 36; 95%) successfully accessed their care plans online and spent a median of 12 minutes (range, 0.5 to 61.9 minutes) reviewing them. Survivors perceived the plans as useful and did not generally report difficulty in accessing them online or understanding content. CONCLUSION: Rapid care plan creation and delivery within an EHR is possible. Plans were available to all (survivors, oncologists, primary care physicians) via the EHR. Further research is required to explore the barriers to automating data importation into plans as well as the impact of EHR-integrated plans.
PURPOSE: The Institute of Medicine (IOM) recommends cancer survivors receive survivorship care plans after completing active cancer treatment. However, care plan creation requires significant time and effort, contributing to diminished adoption of this recommendation. Electronic health record (EHR) systems have been proposed as a solution. We assessed the feasibility of creating and delivering care plans within an EHR system. METHODS: Thirty-eight breast cancer survivors without existing care plans were recruited during a follow-up visit to their primary oncologist. Using an EHR template, an oncologist created an individualized care plan for each participant. Time spent creating each plan was recorded. Participant use and feedback were collected. RESULTS:Participants enrolled a median of 19.7 months after diagnosis (range, 4.3 to 57 months). A minority of IOM-recommended plan elements could be automatically imported without any manual entry. The majority of elements required interpretation and manual import by the clinician. However, with an established infrastructure for importing elements, the time needed to create a care plan electronically was short (median, 3 minutes; range 2 to 12 minutes). Most survivors (n = 36; 95%) successfully accessed their care plans online and spent a median of 12 minutes (range, 0.5 to 61.9 minutes) reviewing them. Survivors perceived the plans as useful and did not generally report difficulty in accessing them online or understanding content. CONCLUSION: Rapid care plan creation and delivery within an EHR is possible. Plans were available to all (survivors, oncologists, primary care physicians) via the EHR. Further research is required to explore the barriers to automating data importation into plans as well as the impact of EHR-integrated plans.
Authors: Carla Parry; Erin E Kent; Angela B Mariotto; Catherine M Alfano; Julia H Rowland Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-10 Impact factor: 4.254
Authors: Arnold L Potosky; Paul K J Han; Julia Rowland; Carrie N Klabunde; Tenbroeck Smith; Noreen Aziz; Craig Earle; John Z Ayanian; Patricia A Ganz; Michael Stefanek Journal: J Gen Intern Med Date: 2011-07-22 Impact factor: 5.128
Authors: Talya Salz; Kevin C Oeffinger; Peter R Lewis; Robert L Williams; Robert L Rhyne; Mark W Yeazel Journal: J Am Board Fam Med Date: 2012 Sep-Oct Impact factor: 2.657
Authors: Lisa Cadmus-Bertram; Amye J Tevaarwerk; Mary E Sesto; Ronald Gangnon; Brittany Van Remortel; Preshita Date Journal: J Cancer Surviv Date: 2019-07-01 Impact factor: 4.442
Authors: SarahMaria Donohue; Mary E Sesto; David L Hahn; Kevin A Buhr; Elizabeth A Jacobs; James M Sosman; Molly J Andreason; Douglas A Wiegmann; Amye J Tevaarwerk Journal: J Oncol Pract Date: 2015-03-24 Impact factor: 3.840
Authors: Colleen M Morken; Amye J Tevaarwerk; Amanda K Swiecichowski; James E Haine; Zachary T Williams; Kirsten Norslien; Natalia Arroyo; Xiao Zhang; Bethaney Campbell; Eneida A Mendonca; Mark B Juckett; Mary E Sesto Journal: Biol Blood Marrow Transplant Date: 2019-02-11 Impact factor: 5.742
Authors: Heather Greenlee; Christine L Sardo Molmenti; Katherine D Crew; Danielle Awad; Kevin Kalinsky; Lois Brafman; Deborah Fuentes; Zaixing Shi; Wei-Yann Tsai; Alfred I Neugut; Dawn L Hershman Journal: J Cancer Surviv Date: 2016-04-21 Impact factor: 4.442
Authors: Kristine K Browning; Alai Tan; Rupa Ghosh-Berkebile; Denise Schimming; Rachee Hatfield; Patrick DiMeo; Maryam B Lustberg; Dori L Klemanski Journal: J Cancer Surviv Date: 2019-08-31 Impact factor: 4.442
Authors: Echo L Warner; Yelena P Wu; Claire C Hacking; Jennifer Wright; Holly L Spraker-Perlman; Emmie Gardner; Anne C Kirchhoff Journal: J Cancer Educ Date: 2015-12 Impact factor: 2.037
Authors: Rebecca E Hill; Claire E Wakefield; Richard J Cohn; Joanna E Fardell; Mary-Ellen E Brierley; Emily Kothe; Paul B Jacobsen; Kate Hetherington; Rebecca Mercieca-Bebber Journal: Oncologist Date: 2019-10-25
Authors: Rebecca E Hill; Claire E Wakefield; Richard J Cohn; Joanna E Fardell; Mary-Ellen E Brierley; Emily Kothe; Paul B Jacobsen; Kate Hetherington; Rebecca Mercieca-Bebber Journal: Oncologist Date: 2019-10-25
Authors: SarahMaria Donohue; James E Haine; Zhanhai Li; David A Feldstein; Mark Micek; Elizabeth R Trowbridge; Sandra A Kamnetz; James M Sosman; Lee G Wilke; Mary E Sesto; Amye J Tevaarwerk Journal: J Cancer Educ Date: 2019-04 Impact factor: 2.037